zk1211484.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 15, 2012

PLURISTEM THERAPEUTICS INC.
(Exact Name of Registrant as Specified in Its Charter)

Nevada
(State or Other Jurisdiction of Incorporation)

001-31392
  
98-0351734
(Commission File Number)
  
(IRS Employer Identification No.)

MATAM Advanced Technology Park
Building No. 20
Haifa, Israel
  
31905
(Address of Principal Executive Offices)
  
(Zip Code)

011 972 74 710 7171
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 5.07.  Submission of Matters to a Vote of Security Holders.

Pluristem Therapeutics Inc. (the “Company”), held its annual meeting of stockholders on May 15, 2012. The results of the stockholder voting at the annual meeting are set forth below.

PROPOSAL NO. 1 — ELECTION OF DIRECTORS.

The stockholders elected the following individuals as directors of the Company to hold office until the next annual meeting of shareholders and until their successors shall have been duly elected and qualified.

Director Name
  
For
    
Against
    
Abstain
    
Broker Non-Votes
  
                         
Zami Aberman
     13,231,845       2,460,819       36,245       0  
                                 
Israel Ben-Yoram
     15,484,872       24,777       219,260       0  
                                 
Isaac Braun
     15,490,198       20,451       218,260       0  
                                 
Mark Germain
     15,346,513       164,136       218,260       0  
                                 
Moria Kwiat
     15,485,953       24,696       218,260       0  
                                 
Hava Meretzki
     15,493,252       76,104       159,553       0  
                                 
Nachum Rosman
     15,478,071       32,577       218,261       0  
                                 
Doron Shorrer
     15,395,837       114,812       218,260       0  

The results reported above are final voting results.
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
PLURISTEM THERAPEUTICS INC.
  
     
Date: May 15, 2012
By:
/s/ Yaky Yanay
  
 
Name:
Yaky Yanay
  
 
Title:
Chief Financial Officer
  

 2